(Q43593305)

25 November 2017

title

Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease (English)

1 reference

25 November 2017

0 references

0 references

0 references

3

1 reference

25 November 2017

4

1 reference

25 November 2017

12

1 reference

Alzheimer's Disease Neuroimaging Initiative

25 November 2017

15

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

25 November 2017

Eduard Vilaplana

2

0 references

author name string

Juan Fortea

1

1 reference

25 November 2017

María-Belén Sánchez-Saudinos

5

1 reference

25 November 2017

Isabel Sala

6

1 reference

25 November 2017

Sofía Antón-Aguirre

7

1 reference

25 November 2017

Sofía González

8

1 reference

25 November 2017

Santiago Medrano

9

1 reference

25 November 2017

Jordi Pegueroles

10

1 reference

25 November 2017

Estrella Morenas

11

1 reference

25 November 2017

Rafael Blesa

13

1 reference

25 November 2017

Alberto Lleó

14

1 reference

25 November 2017

publication date

13 June 2014

1 reference

25 November 2017

1 reference

25 November 2017

volume

76

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

223-230

1 reference

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

25 November 2017

cites work

1 reference

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

Brain injury biomarkers are not dependent on β-amyloid in normal elderly

21 January 2018

1 reference

Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.

21 January 2018

1 reference

Amyloid-β associated cortical thinning in clinically normal elderly

21 January 2018

1 reference

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

21 January 2018

1 reference

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

21 January 2018

1 reference

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

21 January 2018

1 reference

Beta-amyloid burden is not associated with rates of brain atrophy

21 January 2018

1 reference

Larger temporal volume in elderly with high versus low beta-amyloid deposition

21 January 2018

1 reference

Amyloid burden and neural function in people at risk for Alzheimer's Disease

21 January 2018

1 reference

Brain changes in older adults at very low risk for Alzheimer's disease

21 January 2018

1 reference

Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.

21 January 2018

1 reference

Amyloid-β associated volume loss occurs only in the presence of phospho-tau

21 January 2018

1 reference

Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau

21 January 2018

1 reference

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

Measuring the thickness of the human cerebral cortex from magnetic resonance images

21 January 2018

1 reference

Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4.

21 January 2018

1 reference

Apolipoprotein E ε4-related thickening of the cerebral cortex modulates selective attention

21 January 2018

1 reference

Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons

21 January 2018

1 reference

Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice.

21 January 2018

1 reference

Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.

21 January 2018

1 reference

Tau pathology and neurodegeneration

21 January 2018

1 reference

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

21 January 2018

1 reference

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

21 January 2018

1 reference

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model

21 January 2018

1 reference

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

21 January 2018

1 reference

Tau is essential to beta -amyloid-induced neurotoxicity

21 January 2018

1 reference

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease

21 January 2018

1 reference

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

21 January 2018

1 reference

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.24186

1 reference

25 November 2017

1 reference